Overview
Rachel G. Greenberg, MD, MB, MHS is a neonatologist and Professor of Pediatrics at Duke University Medical Center and Duke Clinical Research Institute. Dr. Greenberg’s research focuses on improving safety and efficacy of drugs in infants and children, particularly through her efforts as a Principal Investigator and Steering Committee Chair for the NICHD-funded Pediatric Trials Network. She is also alternate PI of the North Carolina clinical Center for the Neonatal Research Network and PI of the NICHD-funded HEAL KIDS Pain Resource and Data Center. In addition, she has been principal investigator of multiple trials funded by the U.S. Food and Drug Administration, Centers for Disease Control, and National Institutes of Health.
Current Appointments & Affiliations
Professor of Pediatrics
·
2025 - Present
Pediatrics, Neonatology,
Pediatrics
Member in the Duke Clinical Research Institute
·
2016 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
What is the role of diuretics in the prevention and management of bronchopulmonary dysplasia?
Journal Article Curr Treat Options Pediatr · December 2026 PURPOSE OF REVIEW: This review critically examines the role of furosemide and chlorothiazide in the prevention and management of bronchopulmonary dysplasia (BPD). We describe their common use, pharmacotherapeutic mechanisms, and summarize evidence from cli ... Full text Link to item CiteTrends in gabapentin use in a single-center neonatal intensive care unit from 2016-2024.
Journal Article J Perinatol · April 7, 2026 Full text Link to item CiteComparison of neonatal outcomes of term neonates with meconium-stained amniotic fluid before and after routine endotracheal suctioning strategy at birth.
Journal Article J Perinatol · March 31, 2026 OBJECTIVES: To compare the incidence of meconium aspiration syndrome (MAS) among neonates born through meconium-stained amniotic fluid (MSAF) before and after discontinuation of endotracheal suctioning for non-vigorous neonates. METHODS: We conducted a mul ... Full text Link to item CiteRecent Grants
Best Pharmaceuticals for Children Act Pediatric Trials Network
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2025 - 2032PTN 3.0 Task Order #2_ BPCA Pediatric Drug Development Clinical Trial Infrastructure
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2030Duke-Utah HEAL KIDS Pain Resource and Data Center
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2030View All Grants
Education
Duke University, School of Medicine ·
2017
M.S.
Duke University, School of Medicine ·
2016
M.H.S.C.R.
Duke University, School of Medicine ·
2009
M.D.